Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2006-10-24
2006-10-24
Romeo, David S. (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S372000, C435S375000
Reexamination Certificate
active
07125714
ABSTRACT:
Provided are purified and isolated VEGF-C polypeptides capable of binding to at least one of KDR receptor tyrosine kinase (VEGFR-2) and Flt4 receptor tyrosine kinase (VEGFR-3); analogs of such peptides that have VEGF-C-like or VEGF-like biological activities or that are VEGF or VEGF-C inhibitors; polynucleotides encoding the polypeptides; vectors and host cells that embody the polynucleotides; pharmaceutical compositions and diagnostic reagents comprising the polypeptides; and methods of making and using the polypeptides.
REFERENCES:
patent: 4959314 (1990-09-01), Mark et al.
patent: 5219739 (1993-06-01), Tischer et al.
patent: 5326695 (1994-07-01), Andersson et al.
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 5541103 (1996-07-01), Kanz et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5628781 (1997-05-01), Williams et al.
patent: 5677136 (1997-10-01), Simmons et al.
patent: 5776755 (1998-07-01), Alitalo et al.
patent: 5840580 (1998-11-01), Terstappen et al.
patent: 5858782 (1999-01-01), Long et al.
patent: 5876956 (1999-03-01), Jones et al.
patent: 5932540 (1999-08-01), Hu et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 5952199 (1999-09-01), Davis-Smyth et al.
patent: 5994300 (1999-11-01), Bayne et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6096540 (2000-08-01), Olweus et al.
patent: 6100071 (2000-08-01), Davis-Smyth et al.
patent: 6107046 (2000-08-01), Alitalo et al.
patent: 6130071 (2000-10-01), Alitalo et al.
patent: 6146888 (2000-11-01), Smith et al.
patent: 6221839 (2001-04-01), Alitalo et al.
patent: 6235713 (2001-05-01), Achen et al.
patent: 6245530 (2001-06-01), Alitalo et al.
patent: 6331302 (2001-12-01), Bennett
patent: 6361946 (2002-03-01), Alitalo et al.
patent: 6383484 (2002-05-01), Achen et al.
patent: 6383486 (2002-05-01), Davis-Smyth et al.
patent: 6403088 (2002-06-01), Alitalo et al.
patent: 6451764 (2002-09-01), Lee et al.
patent: 6576608 (2003-06-01), Lee et al.
patent: 6608182 (2003-08-01), Rosen et al.
patent: 6645933 (2003-11-01), Alitalo et al.
patent: 6673343 (2004-01-01), Bennett et al.
patent: 6689580 (2004-02-01), Achen et al.
patent: 6730658 (2004-05-01), Alitalo et al.
patent: 2001/0038842 (2001-11-01), Achen et al.
patent: 2002/0065218 (2002-05-01), Achen et al.
patent: 2002/0102260 (2002-08-01), Achen et al.
patent: 2002/0120123 (2002-08-01), Rosen et al.
patent: 2002/0123481 (2002-09-01), Oliviero
patent: 2002/0127222 (2002-09-01), Achen et al.
patent: 2002/0146420 (2002-10-01), Bennett et al.
patent: 2002/0151489 (2002-10-01), Gavereaux et al.
patent: 2002/0182683 (2002-12-01), Hu et al.
patent: 2002/0197691 (2002-12-01), Sugiyama
patent: 2003/0008357 (2003-01-01), Hu et al.
patent: 2003/0028007 (2003-02-01), Hu et al.
patent: 2003/0091567 (2003-05-01), Alitalo et al.
patent: 2003/0092604 (2003-05-01), Alitalo et al.
patent: 2003/0125537 (2003-07-01), Achen et al.
patent: 2003/0166523 (2003-09-01), Achen et al.
patent: 2003/0166547 (2003-09-01), Oliviero
patent: 2003/0166873 (2003-09-01), Lee et al.
patent: 2003/0170786 (2003-09-01), Rosen et al.
patent: 2003/0175274 (2003-09-01), Rosen et al.
patent: 2003/0176674 (2003-09-01), Rosen et al.
patent: 2003/0180294 (2003-09-01), DeVries
patent: 2003/0211101 (2003-11-01), Wise et al.
patent: 2003/0211988 (2003-11-01), Epstein
patent: 2003/0215921 (2003-11-01), Coleman
patent: 2003/0228283 (2003-12-01), Heinzerling et al.
patent: 2003/0232437 (2003-12-01), Zhang et al.
patent: 2004/0037820 (2004-02-01), Alitalo et al.
patent: 0 506 477 (1992-03-01), None
patent: 0935001 (1999-08-01), None
patent: WO 91/09955 (1991-07-01), None
patent: WO 92/20808 (1992-11-01), None
patent: WO 94/12650 (1994-06-01), None
patent: WO 95/24473 (1995-09-01), None
patent: WO 95/26364 (1995-10-01), None
patent: WO 95/33050 (1995-12-01), None
patent: WO 95/33772 (1995-12-01), None
patent: WO 96/11269 (1996-04-01), None
patent: WO 96/30046 (1996-10-01), None
patent: WO 96/39421 (1996-12-01), None
patent: WO 96/39515 (1996-12-01), None
patent: WO 97/05250 (1997-02-01), None
patent: WO 97/09427 (1997-03-01), None
patent: WO 97/12972 (1997-04-01), None
patent: WO 97/17442 (1997-05-01), None
patent: WO 98/49300 (1997-06-01), None
patent: WO 98/02543 (1997-07-01), None
patent: WO 99/46364 (1999-09-01), None
patent: WO 00/21560 (2000-04-01), None
patent: WO 00/24412 (2000-05-01), None
patent: WO 00/45835 (2000-08-01), None
patent: WO 00/58511 (2000-10-01), None
patent: WO 02/08389 (2002-01-01), None
patent: WO 2004/009773 (2004-01-01), None
Horst Ibelgaufts, Dictionary of Cytokines 1995, VCH Publishers, pp. 123-124.
Joukov et al., EMBO J. Jan. 15, 1996, vol. 15(2): pp. 290-298.
Achen, M.G. et al., “Vascular Endothelial Growth Factor D (VEGF-D) is a Ligand for the Tyrosine Kinases VEGF Receptor 2 (Flk1) and VEGF Receptor 3 (Flt4),”Proceedings of the National Academy of Science, USA, 95:548-553 (Jan. 1998).
Adams, M.D. et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,”Nature, 377(6547 Supplement):3-174 (Sep. 1995).
Alitalo et al., “Vascular Endothelial Growth Factors and Receptors Involved in Angiogenesis,” The 9th International Conference of the International Society of Differentiation (ISD), Development, Cell Differentiation and Cancer, Pisa (Italy), Sep. 28-Oct. 2, 1996, p. 66 (ABSTRACT S22).
Alitalo et al., “Vascular Endothelial Growth Factors B and C and Receptors Involved in Angiogenesis,” German-American Academic Council Foundation (GAAC)/ Stiftung Deutsch-Amerikanisches Akademisches Konzil (DAAK), 2nd Symposium on Current Problems in Molecular Medicine: The Role of Cytokines in Human Disease, Nov. 17-20, 1996, Ringberg Castle, Germany, p. 1 (ABSTRACT).
Andersson et al., “Assignment of Interchain Disulfide Bonds in Platelet-Derived Growth Factor (PDGF) and Evidence for Agonist Activity of Monomeric PDGF,”J. Biol. Chem., 267(16):11260-11266 (Jun. 5, 1992).
Aprelikova et al., “FLT4, A Novel Class III Receptor Tyrosine Kinase in Chromosome 5q33-qter,”Cancer Research, 52 :746-748 (Feb. 1, 1992).
Asahara et al., Isolation of Putative Progenitor Endothelial Cells for Angiogenesis,Science, 275: 964-967 (Feb. 1997).
Auffray et al. H. sapiens partial cDNA sequence: clone c-1wf11. EST-STS Accession No. Z44272. Nov. 6, 1994.
Ausprunk, et al., “Migration and Proliferation of Endothelial Cells in Preformed and Newly Formed Blood Vessels during Tumor Angiogenesis,”Microvasc. Res., 14:53-65 (Jul. 1977).
Basilico et al., “The FGF Family of Growth Factors and Oncogenes,”Adv. Cancer Res., 59:145-165 (1992).
Berse et al., “Vascular Permeability Factor (Vascular Endothelial Growth Factor) Gene is Expressed Differentially in Normal Tissues, Macrophages, and Tumors,”Mol. Biol. Cell., 3:211-220 (Feb. 1992).
Betsholtz et al., “cDNA Sequence and Chromosomal Localization of Human Platelet-Derived Growth Factor A-Chain and Its Expression in Tumor Cells Lines,”Nature, 320:695-699 (Apr. 1986).
Borg et al., “Biochemical Characterization of Two Isoforms of FLT4, a VEGF Receptor-Related Tyrosine Kinase,”Oncogene, 10:973-84 (Mar. 1995).
Bowie et al., “Deciphering the Message in Protein Sequences: tolerance to amino acid substitutions,”Science, 247:1306-1310 (Mar. 16, 1990).
Breier et al., “Expression of Vascular Endothelial Growth Factor During Ebryonic Angiogenesis and Endothelial Cell Differentiation,”Development, 114:521-532 (Feb. 1992).
Cao et al., “Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor,”J. Biol. Chem., 271(6):3154-3162 (Feb. 9, 1996).
Capecchi, M.R., “Altering the Genome by Homologous Recombination,”Science, 244:1288-1292 (Jun. 16, 1989).
Chen and Shyu, “Selective Degradation of Early-Response-Gene mRNAs: Functional Analyses of Sequence Features of the AU-Rich Elements,”Mol. Cell Biol., 14(12):8471-8482 (Dec. 1994).
Cheng and Flanagan, “Identification and Cloning of ELF-1, A Devel
Alitalo Kari
Joukov Vladimir
Gamett Daniel C.
Licentia Ltd.
Ludwig Institute for Cancer Research
Marshall & Gerstein & Borun LLP
Romeo David S.
LandOfFree
Progenitor cell materials and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Progenitor cell materials and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progenitor cell materials and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3625606